Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools

NCT01995851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 902

Last updated 2015-05-27

No results posted yet for this study

Summary

Overall, this study will determine (1) the effect of vaccine type (FluMist vs. TIV) on immunization rates, (2) assess the feasibility of school immunization clinics, and (3) inform a larger study to understand the effects of these two vaccines on reducing influenza.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Ontario Agency for Health Protection and Promotion

    collaborator OTHER_GOV
  • Peterborough County-City Health Unit

    collaborator UNKNOWN
  • Dalhousie University

    lead OTHER

Principal Investigators

  • Scott A Halperin, MD, PhD · Nominated Principal Investigator, PHAC/CIHR Influenza Research Network (Dalhousie University)

Eligibility

Min Age
3 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-01-31
Completion
2014-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01995851 on ClinicalTrials.gov